TARS Tarsus Pharmaceuticals reports 1467 percent Q4 2025 revenue growth but wider than expected EPS losses push shares 16 percent lower Goldman Sachs GS Investment Merit Assessment of the ActiveBeta US Large Cap Equity ETF GSLC Is Nuveen NPFD stock outperforming similar companies Nuveen posts 271 EPS and strong quarterly revenue What is the longterm thesis for NOVONIX NVX stock NOVONIX posts 056 EPS loss on record revenue XPeng Inc XPEV Stock Is It an Attractive Investment Q4 2025 Profit Exceeds Views Service SVC Stock Cumulative Volume Edges Up 20260420 Public PPHC Stock Is It an Attractive Investment Slow Drop 20260420 Walmart Inc WMT Faces Elevated DEI Regulatory Risks Amid Broad State and Federal Crackdowns Agree Realty ADC Stock Should You Increase Exposure 013 20260420